• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体前叶腺瘤中DNA指数、S期与侵袭行为之间的关系。对61例进行福尔根阳性DNA分析的细胞计量学研究。

Relationships among DNA Index, S-Phase, and invasive behavior in anterior pituitary adenomas. A cytometric study of 61 cases with Feulgen-positive DNA analysis.

作者信息

Mastronardi L, Guiducci A, Buttaro F M, Cristallini E G, Puzzilli F, Maira G

机构信息

Unit of Neurosurgery, Sandro Pertini Hospital of Rome, Italy.

出版信息

Surg Neurol. 2001 Jul;56(1):27-32. doi: 10.1016/s0090-3019(01)00455-4.

DOI:10.1016/s0090-3019(01)00455-4
PMID:11546567
Abstract

BACKGROUND

Pituitary adenomas are usually well differentiated neoplasms, although in about 1/3 of cases they invade the surrounding dura mater and bone, as confirmed by surgical findings, resulting in a long-term possibility of relapse.

METHODS

To identify the cellular growth rate and to correlate it with surgical evidence of invasiveness, we performed the analysis of DNA with static cytometric quantitation on fresh surgical specimens, using a computer-assisted image processor. The DNA index and the percentage of cells in S-phase (%SPh) were obtained in 61 pituitary tumors consecutively operated on. In relation to surgically verified infiltration of dura and bone, we identified 39 noninvasive and 22 invasive adenomas. The cavernous sinus (CS) was infiltrated in 13 cases. On the basis of immunohistochemical staining and endocrine activity we recognized 27 nonsecreting and 34 secreting adenomas.

RESULTS

The DNA content was aneuploid in 33 cases (11 nonfunctioning, 22 functioning; p = 0.05); there was no correlation with the invasive behavior of the adenomas. The DNA index ranged between 0.93 and 2.50 (median 1.13); the range of %SPh was 0-12.00% (median 2.54%). In invasive adenomas the mean DNA index was 1.33 (p not significant) and the mean %SPh was 4.03% (p = 0.05). In CS-infiltrating pituitary adenomas, the mean DNA index was 1.44 (p = 0.04) and the mean %SPh was 4.52% (p = 0.05).

CONCLUSIONS

Our preliminary results seem to reveal a correlation between DNA index, %SPh, and invasive behavior of pituitary adenomas, encouraging the use of DNA analysis in the prognostic evaluation of these tumors.

摘要

背景

垂体腺瘤通常是高分化肿瘤,不过约三分之一的病例经手术发现证实会侵犯周围硬脑膜和骨质,这导致了长期复发的可能性。

方法

为确定细胞生长速率并将其与侵袭性的手术证据相关联,我们使用计算机辅助图像处理器对新鲜手术标本进行静态细胞定量DNA分析。在连续接受手术的61例垂体肿瘤中获取了DNA指数和S期细胞百分比(%SPh)。根据手术证实的硬脑膜和骨质浸润情况,我们确定了39例非侵袭性和22例侵袭性腺瘤。13例海绵窦(CS)受到浸润。基于免疫组化染色和内分泌活性,我们识别出27例无分泌功能和34例有分泌功能的腺瘤。

结果

33例(11例无功能,22例有功能;p = 0.05)的DNA含量为非整倍体;与腺瘤的侵袭行为无相关性。DNA指数范围在0.93至2.50之间(中位数为1.13);%SPh范围为0 - 12.00%(中位数为2.54%)。侵袭性腺瘤的平均DNA指数为1.33(p无统计学意义),平均%SPh为4.03%(p = 0.05)。在浸润海绵窦的垂体腺瘤中,平均DNA指数为1.44(p = 0.04),平均%SPh为4.52%(p = 0.05)。

结论

我们的初步结果似乎揭示了DNA指数、%SPh与垂体腺瘤侵袭行为之间的相关性,这鼓励在这些肿瘤的预后评估中使用DNA分析。

相似文献

1
Relationships among DNA Index, S-Phase, and invasive behavior in anterior pituitary adenomas. A cytometric study of 61 cases with Feulgen-positive DNA analysis.垂体前叶腺瘤中DNA指数、S期与侵袭行为之间的关系。对61例进行福尔根阳性DNA分析的细胞计量学研究。
Surg Neurol. 2001 Jul;56(1):27-32. doi: 10.1016/s0090-3019(01)00455-4.
2
Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody.垂体前叶腺瘤的Ki-67标记指数与侵袭性:使用MIB-1单克隆抗体对103例病例的分析
J Clin Pathol. 1999 Feb;52(2):107-11. doi: 10.1136/jcp.52.2.107.
3
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.354例接受经蝶窦手术治疗的垂体腺瘤患者中显微镜下硬脑膜侵犯的长期意义。
J Neurosurg. 2002 Feb;96(2):195-208. doi: 10.3171/jns.2002.96.2.0195.
4
Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody.促肾上腺皮质激素分泌型垂体腺瘤:使用MIB-1抗体分析生长分数
Tumori. 2000 May-Jun;86(3):229-32. doi: 10.1177/030089160008600310.
5
Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.垂体前叶腺瘤的Ki-67标记指数与肿瘤大小之间缺乏相关性。
BMC Cancer. 2001;1:12. doi: 10.1186/1471-2407-1-12. Epub 2001 Aug 21.
6
Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.垂体腺瘤侵袭海绵窦间隙:内镜验证及其与基于磁共振成像的分类的相关性
J Neurosurg. 2015 Apr;122(4):803-11. doi: 10.3171/2014.12.JNS141083. Epub 2015 Feb 6.
7
Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.垂体腺瘤:192例经临床病理特征分析的肿瘤的DNA流式细胞术研究
Clin Neuropathol. 2005 Mar-Apr;24(2):56-63.
8
Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.复发性人垂体腺瘤的流式细胞术DNA倍体及细胞周期分数。流式细胞术分析与增殖细胞核抗原表达的相关性研究。
Gen Diagn Pathol. 1996 Oct;142(2):89-95.
9
Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.内镜经蝶窦治疗复发性和残留性垂体腺瘤——初步经验
Minim Invasive Neurosurg. 2006 Feb;49(1):10-4. doi: 10.1055/s-2006-932126.
10
Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients.非典型垂体腺瘤:ki-67和p53在预后及治疗评估中的临床特征及作用。50例患者系列研究。
Neurosurg Rev. 2017 Jan;40(1):105-114. doi: 10.1007/s10143-016-0740-9. Epub 2016 May 23.

引用本文的文献

1
Atypical pituitary adenomas: clinical characteristics and role of Ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients.非典型垂体腺瘤:Ki-67和p53在预后及治疗评估中的临床特征及作用。50例患者系列研究。
Neurosurg Rev. 2017 Apr;40(2):357-358. doi: 10.1007/s10143-017-0818-z. Epub 2017 Jan 22.
2
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas.垂体大腺瘤中的细胞增殖参数和细胞凋亡指数。
J Endocrinol Invest. 2012 May;35(5):473-8. doi: 10.3275/7905. Epub 2011 Sep 6.
3
DNA-flow cytometry of 207 pituitary adenomas: ploidy, proliferation, and prognosis.
207例垂体腺瘤的DNA流式细胞术:倍体、增殖与预后
J Endocrinol Invest. 2005 Oct;28(9):795-801. doi: 10.1007/BF03347568.
4
Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma.中度分化肝细胞癌患者预后评估中的病理特征、增殖细胞核抗原标记指数及DNA指数
World J Gastroenterol. 2002 Dec;8(6):1040-4. doi: 10.3748/wjg.v8.i6.1040.
5
Pituitary tumor diagnosis and treatment.垂体瘤的诊断与治疗。
Curr Neurol Neurosci Rep. 2002 May;2(3):236-45. doi: 10.1007/s11910-002-0082-6.